<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34325980</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3061</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Trends in endocrinology and metabolism: TEM</Title><ISOAbbreviation>Trends Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Towards personalized medicine for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>839</StartPage><EndPage>841</EndPage><MedlinePgn>839-841</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tem.2021.07.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1043-2760(21)00155-7</ELocationID><Abstract><AbstractText>Mohassel et al. provide unprecedented dichotomy of consequences on sphingolipid biosynthesis between pathogenic variants in the SPTLC1 gene, responsible for either amyotrophic lateral sclerosis (ALS) or hereditary sensory and autonomic neuropathy type 1 (HSAN1). Normalization of sphingolipid levels by siRNA selectively targeting the ALS mutant allele mRNA sheds light on new therapeutic approaches.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cassereau</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital, Angers, France; Amyotrophic Lateral Sclerosis (ALS) Center, University Hospital, Angers, France; University of Angers, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) and Centre National de la Recherche Scientifique (CNRS) Mitochondrial and Cardiovascular Physiopathology (MitoVasc) Institute, Angers, France. Electronic address: JuCassereau@chu-angers.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ALS Center, Centre Hospitalier Universitaire (CHU) Bretonneau, Tours, France; INSERM Unit U1253 Imaging and Brain, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Angers, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) and Centre National de la Recherche Scientifique (CNRS) Mitochondrial and Cardiovascular Physiopathology (MitoVasc) Institute, Angers, France; Department of Biochemistry and Molecular Biology, University Hospital, Angers, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Trends Endocrinol Metab</MedlineTA><NlmUniqueID>9001516</NlmUniqueID><ISSNLinking>1043-2760</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013107">Sphingolipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009477" MajorTopicYN="Y">Hereditary Sensory and Autonomic Neuropathies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013107" MajorTopicYN="N">Sphingolipids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SPTLC1 gene</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">siRNA</Keyword><Keyword MajorTopicYN="N">sphingolipids</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34325980</ArticleId><ArticleId IdType="doi">10.1016/j.tem.2021.07.002</ArticleId><ArticleId IdType="pii">S1043-2760(21)00155-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>